- Home
- FIS vs VCYT Comparison
FIS vs VCYT Comparison
Compare FIS & VCYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FIS | VCYT |
|---|---|---|
| Founded | 1968 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 34.0B | 2.9B |
| IPO Year | N/A | 2013 |
Fundamental Metrics
Financial Performance| Metric | FIS | VCYT |
|---|---|---|
| Price | $67.11 | $42.93 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 17 | 8 |
| Target Price | ★ $85.50 | $45.38 |
| AVG Volume (30 Days) | ★ 2.8M | 1.0M |
| Earning Date | 11-05-2025 | 11-04-2025 |
| Dividend Yield | ★ 2.38% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.29 | ★ 0.38 |
| Revenue | ★ $10,464,000,000.00 | $495,141,000.00 |
| Revenue This Year | $5.80 | $16.02 |
| Revenue Next Year | $4.55 | $10.74 |
| P/E Ratio | $231.71 | ★ $112.61 |
| Revenue Growth | 4.21 | ★ 16.41 |
| 52 Week Low | $59.51 | $22.61 |
| 52 Week High | $85.85 | $50.71 |
Technical Indicators
Market Signals| Indicator | FIS | VCYT |
|---|---|---|
| Relative Strength Index (RSI) | 57.49 | 50.52 |
| Support Level | $64.98 | $45.68 |
| Resistance Level | $66.93 | $45.17 |
| Average True Range (ATR) | 1.37 | 1.95 |
| MACD | 0.24 | -0.70 |
| Stochastic Oscillator | 74.68 | 16.81 |
Price Performance
Historical ComparisonAbout FIS Fidelity National Information Services Inc.
Fidelity National Information Services provides core processing and ancillary services to banks, but its business has expanded over time. By acquiring SunGard in 2015, the company now provides record-keeping and other services to investment firms. With the acquisition of Worldpay in 2019, FIS was providing payment processing services for merchants and holding leading positions in the United States and United Kingdom. But the company sold off a majority interest in Worldpay and now has only a minority stake.
About VCYT Veracyte Inc.
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder). In addition, its Percepta Nasal Swab test is being run in CLIA labs in support of clinical studies.